Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05768529RecruitingPhase 1/Phase 2
U16 cell therapy for relapsed or refractory B-cell lymphoma
This trial tests a new cell therapy called U16 for people with certain types of B-cell lymphoma that have come back or not responded to previous treatments. The therapy uses your own immune cells to target and attack the cancer cells.
Changsha, HunanAges 18–70 - NCT05762055Enrolling by invitation
Compare two neck fusion methods for arthritis pain
This study compares two ways of doing neck fusion surgery for people with age-related (degenerative) problems in the cervical spine. It may help surgeons learn which method works best for healing and long-term outcomes.
Dallas, TexasAges 18–99 - NCT05747729RecruitingPhase 1/Phase 2
Study of surufatinib, serplulimab, chemo for neuroendocrine carcinoma
This trial tests a combination of two targeted therapies (surufatinib and serplulimab) plus standard chemotherapy (platinum and etoposide) for people with a rare, aggressive type of cancer called neuroendocrine carcinoma that started outside the lung. The goal is to see if this new combination works better than chemotherapy alone.
Wuhan, HubeiAges 18 years+ - NCT05721261Recruiting
Electrical stimulation to help a newly injured nerve heal
This trial is testing whether temporary electrical stimulation can help regenerate, or regrow, a nerve after an acute (recent) injury. It may be relevant if you have a new peripheral nerve injury, but it likely would not be for people with peripheral neuropathy or certain implanted devices.
Gainesville, FloridaAges 18–65 - NCT05739331Recruiting
AI-assisted breathing test to check swollen chest lymph nodes
This trial uses an AI-supported breathing procedure to help doctors examine enlarged lymph nodes in the chest when the cause is still unknown. It may help improve how accurately and efficiently doctors assess these lymph nodes so you can get answers sooner.
LevangerAges 18 years+ - NCT05731427Recruiting
Study on what drives bronchiectasis worsening
This study looks at why bronchiectasis gets worse over time. It may help doctors understand the disease better and find better ways to monitor or treat it.
Guiyang, GuizhouAges 18 years+ - NCT05721911Recruiting
Study using brain-cell tests to better understand Parkinson’s risk
This study collects blood and related samples to create a “biobank” and uses lab tests to study genetic risk in Parkinson’s disease and idiopathic REM sleep behavior disorder (RBD). It may help researchers understand why symptoms develop and improve future prevention or treatment approaches.
Milan, ItalyAges 18 years+ - NCT05685433Recruiting
Real-world study of eCoin for urgent urine leaks
This study looks at how well eCoin (a device treatment) reduces urgent urine leaks in people with overactive bladder. It’s a “real-world” evaluation, meaning it aims to reflect everyday care after the device is already approved.
Homewood, AlabamaAges 18 years+ - NCT05701982Recruiting
Walking plus Tai Chi coach via video for COPD and pain
This study tests whether a phone/computer program that combines walking training with Tai Chi improves physical function (how well you move) in people who have COPD and long-term body or muscle pain. It may help you build strength, balance, and safer movement—especially if pain makes activity hard.
Boston, MassachusettsAges 40–100 - NCT05674539Enrolling by invitationPhase 3
Less intense transplant regimen for AML or MDS patients
This trial tests whether a less intense chemotherapy and transplant plan can work for adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are getting a stem cell transplant. It may help reduce transplant-related harm, especially in people considered higher risk due to age or other health factors.
Wuhan, HubeiAges 18 years+ - NCT05650229RecruitingPhase 2
Study of KL1333 for adult mitochondrial disease fatigue and weakness
This Phase 2 trial studies whether KL1333 improves chronic fatigue and muscle weakness in adults with a confirmed mitochondrial genetic disease. You may be eligible if you have persistent fatigue for at least 3 months and signs of muscle involvement, and can safely follow study requirements.
Orange, CaliforniaAges 18 years+ - NCT05661032Recruiting
Testing new ways to identify respiratory viruses
This study tests “new technologies” to identify what virus is causing a respiratory illness, using samples taken from inside your nose. It may help doctors get faster, more accurate answers about the cause of your symptoms.
Portsmouth, HampshireAges Any age - NCT05639595Recruiting
Mobile app for mothers and babies in cambodia
This study tests a mobile app that gives mothers and pregnant women health tips for themselves and their babies. The goal is to improve health for both mom and child.
Battambang, BattambangAges 18–49 - NCT05662462Recruiting
Phone coaching to keep blood sugar in range during pregnancy
This study tests whether technology plus coaching can help pregnant people with type 2 diabetes keep their blood sugar in a healthy target range. You may use a smartphone app and, if assigned to that group, a device that tracks glucose continuously.
Columbus, OhioAges 18 years+ - NCT05649059RecruitingPhase 4
Cannabidiol study for social anxiety symptoms
This trial studies whether cannabidiol (CBD) helps improve social anxiety symptoms. You may be able to join if you are an adult with significant social anxiety and meet medication and health safety requirements.
Cambridge, MassachusettsAges 18–55 - NCT05650411Recruiting
Test new drug-eluting stent with less blood thinner
This study compares a new type of “drug-eluting” stent (a tiny scaffold that slowly releases medicine) and a single blood-thinner plan versus the usual two-drug blood thinner plan after stent placement in the left main coronary artery. It aims to see if the simpler plan can work while keeping the stent safe.
Zurich, Canton of ZurichAges 18 years+ - NCT05655195Recruiting
At-home light and sound therapy for mild Alzheimer’s
This study tests whether regular at-home “gamma” light and sound stimulation can help people with mild Alzheimer’s. Participants start with a month at home and are followed to see how they do during treatment.
Cambridge, MassachusettsAges 65–100 - NCT05654272Recruiting
Testing CIRC imaging technology for people with heart problems
This study is developing and testing CIRC technologies using heart imaging. You may be able to join if you’re an adult with cardiovascular (heart) disease and can safely have the MRI scans.
Cleveland, OhioAges 18 years+ - NCT05626712RecruitingPhase 1/Phase 2
CELZ-201 to preserve insulin production in early type 1 diabetes
This Phase 1/2 study tests whether CELZ-201 is safe and can help the body keep making some of its own insulin in people who were recently diagnosed with type 1 diabetes. You may be eligible if your diabetes started within the past year and your tests show you still have some insulin-making activity.
Miami, FloridaAges 18–35 - NCT05615259Recruiting
Compare personalized shoulder surgery with standard tools
This trial compares a personalized, guided approach to shoulder replacement (reverse shoulder arthroplasty) versus the usual surgical tools. It aims to see whether the guided method improves outcomes and implant performance over at least 2 years.
Gouda, HHAges 21 years+ - NCT05620095Recruiting
Drug-coated balloon angioplasty for lower leg artery blockages
This trial tests whether a drug-coated balloon can better reopen blocked arteries in the lower leg (below the knee). It may help keep blood flow open and reduce the chance the blockage comes back, after a procedure to cross and open the narrowed area.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05632107Recruiting
Testing two monitors that check muscle relaxation during surgery
This trial compares two devices that measure how well muscle relaxant medicine is working during planned surgery. It may help anesthesiologists choose monitoring that improves safety by confirming the muscles are relaxing as intended.
Wuhan, HubeiAges 18–90 - NCT05625724RecruitingPhase 3
Aspirin to help prevent pregnancy complications after IVF
This Phase 3 study tests whether daily low-dose aspirin can reduce the risk of preeclampsia (dangerous high blood pressure in pregnancy) and improve pregnancy outcomes for people who got pregnant using assisted reproduction like IVF. It mainly targets pregnancies early on (about 9–14 weeks).
AngersAges 18 years+ - NCT00201526Recruiting
BRAIN study for people who can consent
This study enrolls patients who are able to understand the study and voluntarily agree to participate in writing. It aims to learn from participants to improve research and innovation related to bipolar illness and care.
TrondheimAges Any age
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.